An additional 8 targets (CXCL6, IFI44, IFI44L, RSAD2, S100A8, SPRR2A, SYNE1, XAF1) are associated with COVID-19 pathogenesis, but do not have therapies targeting them available for potential repurposing. The gene discussed is SYNE1; the disease is COVID-19.